HIV 1 News and Research

RSS

RBHS Chancellor leads study to eliminate chronic viral hepatitis

Chronic viral hepatitis has a reputation for being a silent killer. The infection often goes undetected until the symptoms of advanced liver cancer appear. By that point, a patient has a five-year survival rate, according to the American Cancer Society.

17 Dec 2015

UMMS researchers identify new life cycle stage in HIV infection

Researchers at the University of Massachusetts Medical School have identified a new life cycle stage in HIV infection, thanks to a novel technique they developed to take images of intact infected cells.

17 Dec 2015

Study offers new view of how cancer cells transform normal cells through 'metastatic hijacking'

Metastasis - or the spread of cancer from one part of the body to other parts - accounts for more than 90 percent of cancer-related deaths. Although the cells that seed metastasis and the sites that they tend to travel to have been increasingly studied over the years, little has been known about how cancer migrates from a primary site, such as breast tissue, to a secondary site, such as the brain or bone marrow.

16 Dec 2015

TSRI scientists track how HIV-fighting antibodies develop over time

In a new study, a team led by scientists at The Scripps Research Institute tracked how a family of these HIV-fighting antibodies develops over time. The research shows how a future vaccine might trigger the immune system to produce these antibodies more effectively.

16 Dec 2015

Global Health Impact Index can measure actual impact of drugs worldwide

Billions of dollars have been spent on developing drugs and supplying them around the world, but which companies' drugs are actually making an impact? The Global Health Impact Index, headed by Binghamton University Associate Professor Nicole Hassoun and highlighted in a new article published Friday in PLOS ONE, addresses this issue by ranking pharmaceutical companies based on their drugs' impact on global health.

15 Dec 2015

New rapid test can detect malaria parasites, viruses and biomarkers

Nothing could be simpler: a drop of blood is placed on a special carrier substance; after a wait of a few minutes, the slide is placed on a device that emits polarised light thanks to an inexpensive polarisation filter. It is covered with a lid containing a second polarisation filter, which blocks the light from all materials except crystalline or materials with directional properties.

13 Dec 2015

Access to harm reduction programs vey low in rural and suburban areas affected by HIV infections

Access to harm reduction programs such as syringe exchange is lowest in rural and suburban areas, where rates of addiction to heroin and other opioids are on the rise, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and published online today in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

12 Dec 2015

AIDS treatment can improve well-being of HIV-negative people

In rural Malawi, roughly 10 percent of the adult population has HIV. At the peak of the epidemic, in the 1990s and early 2000s, nearly everyone knew someone infected with or affected by the virus, what demographer Hans-Peter Kohler of the University of Pennsylvania describes as a generalized epidemic.

12 Dec 2015

Sangamo presents Phase 2 data from two ongoing clinical trials of SB-728-T for treatment of HIV/AIDS

Sangamo BioSciences, Inc., the leader in therapeutic genome editing, announced the presentation of Phase 2 data from two of the Company's ongoing clinical trials (SB-728-1101 Cohort 3* and SB-728-mR-1401) of SB-728-T, which is being developed for the functional control of HIV/AIDS.

11 Dec 2015

TB sidetracked in the fight against HIV epidemic in Malawi

Tuberculosis seems to have fallen between the cracks in poverty-stricken Malawi's sponsor-dependent health sector. The dominating focus on HIV may have left parts of Africa with a skewed health service, say researchers.

11 Dec 2015

WHO launches new comprehensive analysis of global health trends

The World Health Organization (WHO) today launched a new comprehensive analysis of global health trends since 2000 and an assessment of the challenges for the next 15 years.

10 Dec 2015

Young men with HIV engage in risky sexual behavior

Young men who have sex with men and have detectable levels of HIV were more likely to report not using a condom during anal intercourse with a partner not infected with HIV, compared with virologically suppressed young men who have sex with men, according to researchers at Columbia University's Mailman School of Public Health.

8 Dec 2015

FIRS calls for continued international support to end AIDS epidemic by 2030

World AIDS Day, held annually on the first day of December each year since 1988, is an opportunity for people around the world to join in the fight, show their support for those living with human immunodeficiency virus (HIV), and commemorate the lives of those who have died.

7 Dec 2015

WHO highlights need to expand antiretroviral therapy, reverse HIV epidemic on World AIDS Day

On World AIDS Day the World Health Organization emphasizes that expanding antiretroviral therapy to all people living with HIV is key to ending the AIDS epidemic within a generation.

7 Dec 2015

WHO Prequalification of IVDs Programme accepts Beckman Coulter’s Aquios CL flow cytometer

Beckman Coulter Life Sciences announce that their Aquios CL flow cytometer has been accepted by the World Health Organization (WHO) Prequalification of In Vitro Diagnostics Programme. It can now be used specifically for the immunologic assessment of patients having, or suspected of having, immune deficiency.

7 Dec 2015

World Hepatitis Alliance highlights need to recognise impact of coinfection between HIV and viral hepatitis

Viral hepatitis is one of the leading causes of non-AIDS-related deaths among people living with HIV, yet often goes undiagnosed. Similar to HIV, the hepatitis B and hepatitis C viruses are blood-borne, having similar transmission routes like sexual contact for hepatitis B and injection drug use and sexual contact for hepatitis C.

7 Dec 2015

HIV 1 News and Research

RBHS Chancellor leads study to eliminate chronic viral hepatitis

UMMS researchers identify new life cycle stage in HIV infection

Study offers new view of how cancer cells transform normal cells through 'metastatic hijacking'

TSRI scientists track how HIV-fighting antibodies develop over time

Global Health Impact Index can measure actual impact of drugs worldwide

New rapid test can detect malaria parasites, viruses and biomarkers

Access to harm reduction programs vey low in rural and suburban areas affected by HIV infections

AIDS treatment can improve well-being of HIV-negative people

Sangamo presents Phase 2 data from two ongoing clinical trials of SB-728-T for treatment of HIV/AIDS

TB sidetracked in the fight against HIV epidemic in Malawi

WHO launches new comprehensive analysis of global health trends

Young men with HIV engage in risky sexual behavior

FIRS calls for continued international support to end AIDS epidemic by 2030

WHO highlights need to expand antiretroviral therapy, reverse HIV epidemic on World AIDS Day

WHO Prequalification of IVDs Programme accepts Beckman Coulter’s Aquios CL flow cytometer

World Hepatitis Alliance highlights need to recognise impact of coinfection between HIV and viral hepatitis

WHO recommends new strategies to treat HIV patients, reduce new infections

Asia-Pacific adolescents face higher risk of HIV, account for 15% of new infections

MPP collaborates with University of Liverpool to accelerate development of HIV nanomedicines

Establishing supervised injection facilities in Toronto and Ottawa would be cost-effective, say researchers

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News